Infection by exosome-carried Coxsackievirus B3 induces immune escape resulting in an aggravated pathogenesis

Microbes Infect. 2023 Sep-Oct;25(7):105148. doi: 10.1016/j.micinf.2023.105148. Epub 2023 May 6.

Abstract

Increasing evidence has shown that extracellular vesicles or exosomes released from virus-infected cells contain viral particles, genomes, or other pathogenic factors that move to neighbor cells, contributing to virus dissemination and productive infection. Our recent study demonstrated that exosomes carrying CVB3 virions exhibited greater infection efficiency than free virions because they accessed various entry routes, overcoming restrictions to viral tropism. However, the pathogenicity of exosomes carried CVB3 and their effect on immunological properties have not yet been completely explained. In the current study, we sought to explore whether exosomes exert their effect on the CVB3-induced pathogenesis or evade the immune attack. Our results showed that exosomes-carried CVB3 could effectively infect viral receptor-negative immune cells in vivo, resulting in inducing immune system loss. Importantly, the exosomes-carried CVB3 had the ability to escape the neutralizing antibodies activity resulting in inducing the severe onset of myocarditis. Using the genetically engineered mouse with deficiency of exosomes, we observed that the exosomes-carried CVB3 reinforced an aggravated pathogenesis. By understanding how exosomes promote the course of viral disease, clinical applications of exosomes can be developed.

Keywords: Coxsackievirus B3; Exosomes; Immune escape; Viral pathogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Neutralizing
  • Coxsackievirus Infections* / pathology
  • Enterovirus B, Human
  • Exosomes* / pathology
  • Mice
  • Myocarditis* / pathology

Substances

  • Antibodies, Neutralizing